VAERS Explorer
Back to explore

Report #2883465

Received Jan 30, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
TX
Recovered
Unknown
Vaccinated
Jan 27, 2026
Onset
Jan 27, 2026
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HPV9HPV (GARDASIL 9)MERCK & CO. INC.UNKZ011088—

Symptoms (2)

No adverse eventProduct storage error

Symptom narrative

No symptoms reported. No additional AE.; GARDASIL 9 which underwent a temperature excursion was administered.; This spontaneous report was received from a registered nurse (RN) and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, past medications and concomitant medications were not reported. On 27-Jan-2026, the patient was vaccinated with improperly stored dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) suspension for injection, 0.50 ml, lot# Z011088, expiration date: 06-Aug-2027 (dose number, route of administration and anatomical location were not reported), for prophylaxis (Product storage error). On an unknown date before administration, the vaccine underwent a temperature excursion of 47 degrees Fahrenheit (F) (46.6 F) for 88 hours. There was no previous temperature excursion. No additional adverse event was reported.